Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimozide for Post-COVID Tinnitus
NCT05507372Unknown
- Start
- Oct 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
01
Overview
Randomised trial of pimozide in tinnitus (2 arms). Primary endpoint: Tinnitus Handicap Inventory at 4 weeks. Status: unknown.
02
Drugs
pimozide
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT05507372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507372.